Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
-1.01 %
$ 42.2 M
Market Cap
-2.2
P/E
LTRN - GROSS PROFIT
Gross Profit LTRN - Lantern Pharma Inc.
-175 K
LAST VALUE
-33.97%
2 YEAR CAGR
-133.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR